These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22178134)

  • 1. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI).
    Yu H; Li Q; Wang D; Shi L; Lu G; Sun L; Wang L; Zhu W; Mak YT; Wong N; Wang Y; Pan F; Yew DT
    Neurotoxicology; 2012 Jan; 33(1):70-7. PubMed ID: 22178134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys.
    Sun L; Li Q; Li Q; Zhang Y; Liu D; Jiang H; Pan F; Yew DT
    Addict Biol; 2014 Mar; 19(2):185-94. PubMed ID: 23145560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats.
    Nelson CL; Burk JA; Bruno JP; Sarter M
    Psychopharmacology (Berl); 2002 May; 161(2):168-79. PubMed ID: 11981597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.
    Musso F; Brinkmeyer J; Ecker D; London MK; Thieme G; Warbrick T; Wittsack HJ; Saleh A; Greb W; de Boer P; Winterer G
    Neuroimage; 2011 Sep; 58(2):508-25. PubMed ID: 21723949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?
    Stefanovic A; Brandner B; Klaassen E; Cregg R; Nagaratnam M; Bromley LM; Das RK; Rossell SL; Morgan CJ; Curran HV
    J Clin Psychopharmacol; 2009 Apr; 29(2):124-33. PubMed ID: 19512973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice.
    Chatterjee M; Verma R; Ganguly S; Palit G
    Neuropharmacology; 2012 Nov; 63(6):1161-71. PubMed ID: 22683513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine administration disturbs behavioural and distributed neural correlates of fear conditioning in the rat.
    Pietersen CY; Bosker FJ; Postema F; Fokkema DS; Korf J; den Boer JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1209-18. PubMed ID: 16626845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency.
    Nagels A; Kirner-Veselinovic A; Krach S; Kircher T
    Neuroimage; 2011 Jan; 54(2):1307-14. PubMed ID: 20727411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effects of NMDA antagonism: from the rodent to the human brain.
    Gunduz-Bruce H
    Brain Res Rev; 2009 May; 60(2):279-86. PubMed ID: 18703087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure.
    Enomoto T; Floresco SB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):668-75. PubMed ID: 19306904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.
    De Simoni S; Schwarz AJ; O'Daly OG; Marquand AF; Brittain C; Gonzales C; Stephenson S; Williams SC; Mehta MA
    Neuroimage; 2013 Jan; 64():75-90. PubMed ID: 23009959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in regional homogeneity of resting-state brain activity in ketamine addicts.
    Liao Y; Tang J; Fornito A; Liu T; Chen X; Chen H; Xiang X; Wang X; Hao W
    Neurosci Lett; 2012 Jul; 522(1):36-40. PubMed ID: 22698584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain.
    Preece MA; Sibson NR; Raley JM; Blamire A; Styles P; Sharp T
    Synapse; 2007 Nov; 61(11):925-32. PubMed ID: 17701967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.
    Ossowska K; Smiałowska M; Kuter K; Wierońska J; Zieba B; Wardas J; Nowak P; Dabrowska J; Bortel A; Biedka I; Schulze G; Rommelspacher H
    Neuroscience; 2006 Sep; 141(4):2155-65. PubMed ID: 16797138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
    Roberts BM; Holden DE; Shaffer CL; Seymour PA; Menniti FS; Schmidt CJ; Williams GV; Castner SA
    Behav Brain Res; 2010 Sep; 212(1):41-8. PubMed ID: 20347881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice.
    Featherstone RE; Liang Y; Saunders JA; Tatard-Leitman VM; Ehrlichman RS; Siegel SJ
    Neurobiol Dis; 2012 Sep; 47(3):338-46. PubMed ID: 22627142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.